Insulet Corp. widens Q4 loss, falls to 52-week low
Shares of Insulet Corp. (Nasdaq:PODD) have fallen to a new 52-week low on news after the close on Monday that the maker of an insulin infusion system for diabetics widened its fourth-quarter net loss due to a rise in operating expenses. The Bedford, Mass.-based company reported that its net loss for the three months ended Dec. 31, 2007, was $15.7 million, or $0.59 per share, compared with a net loss of $10.9 million or $27.00 per share for the fourth quarter of 2006.
At 1:35 p.m. ET, the stock had declined $1.25, or 9%, to $12.81. The previous 52-week low of $13.28 was set on July 24, 2007. For detailed price information and recent news stories about Insulet, click PODD.
